These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33162180)

  • 1. Reversible corneal stromal thinning, acute-onset white cataract and angle-closure glaucoma due to erdafitinib, a fibroblast growth factor receptor inhibitor: Report of three cases.
    Bauters G; Paques M; Borderie V; Bouheraoua N
    J Fr Ophtalmol; 2021 Jan; 44(1):67-75. PubMed ID: 33162180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors.
    Nishina T; Takahashi S; Iwasawa R; Noguchi H; Aoki M; Doi T
    Invest New Drugs; 2018 Jun; 36(3):424-434. PubMed ID: 28965185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors.
    Shin E; Lim DH; Han J; Nam DH; Park K; Ahn MJ; Kang WK; Lee J; Ahn JS; Lee SH; Sun JM; Jung HA; Chung TY
    BMC Ophthalmol; 2020 Jan; 20(1):19. PubMed ID: 31918686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phacomorphic Angle-closure Following Silicone Oil Tamponade in a Pediatric Patient.
    Leung VC; Fung SSM; Muni R; Ali A
    J Glaucoma; 2018 Jun; 27(6):e106-e109. PubMed ID: 29613981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erdafitinib: A novel therapy for FGFR-mutated urothelial cancer.
    Roubal K; Myint ZW; Kolesar JM
    Am J Health Syst Pharm; 2020 Feb; 77(5):346-351. PubMed ID: 32073123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erdafitinib-Induced Bilateral Multifocal Serous Retinal Detachments and Severe Dry Eye Related Unilateral Peripheral Ulcerative Keratitis in a Patient with Metastatic Urothelial Carcinoma.
    Kayabaşı M; Bilkay Görken İ; Durak İ; Karaoğlu A; Saatci AO
    Eur J Case Rep Intern Med; 2024; 11(6):004556. PubMed ID: 38846673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrous proliferation into anterior segment after acute angle-closure glaucoma.
    Ng Jy; Srinivasan S; Roberts F
    Cornea; 2015 Jan; 34(1):103-6. PubMed ID: 25411932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib.
    Karkera JD; Cardona GM; Bell K; Gaffney D; Portale JC; Santiago-Walker A; Moy CH; King P; Sharp M; Bahleda R; Luo FR; Alvarez JD; Lorenzi MV; Platero SJ
    Mol Cancer Ther; 2017 Aug; 16(8):1717-1726. PubMed ID: 28416604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior segment optical coherence tomography parameters in phacomorphic angle closure and mature cataracts.
    Mansouri M; Ramezani F; Moghimi S; Tabatabaie A; Abdi F; He M; Lin SC
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7403-9. PubMed ID: 25335976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.
    Bahleda R; Italiano A; Hierro C; Mita A; Cervantes A; Chan N; Awad M; Calvo E; Moreno V; Govindan R; Spira A; Gonzalez M; Zhong B; Santiago-Walker A; Poggesi I; Parekh T; Xie H; Infante J; Tabernero J
    Clin Cancer Res; 2019 Aug; 25(16):4888-4897. PubMed ID: 31088831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan fibroblast growth factor receptor inhibitor associated retinopathy.
    Paris A; Bodaghi B; Touhami S
    Eur J Ophthalmol; 2024 May; 34(3):NP66-NP71. PubMed ID: 38086757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPECIFIC CHARACTERISTICS OF OCULAR BIOMETRIC FACTORS IN GLAUCOMATOUS PATIENTS WITH PSEUDOEXFOLIATIVE SYNDROME AS MEASURED BY OPTICAL LOW-COHERENCE REFLECTOMETRY.
    Janjetović Ž; Bušić M; Bosnar D; Barać J; Genda I
    Acta Clin Croat; 2019 Mar; 58(1):87-94. PubMed ID: 31363329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of delayed-onset glaucoma and early-onset glaucoma after infantile cataract surgery.
    Kang KD; Yim HB; Biglan AW
    Korean J Ophthalmol; 2006 Mar; 20(1):41-6. PubMed ID: 16768189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate-associated acute, bilateral, secondary angle-closure glaucoma.
    Fraunfelder FW; Fraunfelder FT; Keates EU
    Ophthalmology; 2004 Jan; 111(1):109-11. PubMed ID: 14711721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying fibroblast growth factor receptor genetic alterations using RNA-based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment.
    Wang S; Burgess M; Major C; English A; Sweeney M; Hartmann A
    J Pathol Clin Res; 2020 Jul; 6(3):207-214. PubMed ID: 32304281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Erdafitinib-induced Central Serous Chorioretinopathy.
    Claiborne RT; Tsan GL
    Optom Vis Sci; 2022 Jan; 99(1):88-92. PubMed ID: 34882600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erdafitinib to treat urothelial carcinoma.
    Hanna KS
    Drugs Today (Barc); 2019 Aug; 55(8):495-501. PubMed ID: 31461086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate-induced acute angle closure with severe panuveitis: A challenging case report.
    Mahendradas P; Parab S; Sasikumar R; Kawali A; Shetty BK
    Indian J Ophthalmol; 2018 Sep; 66(9):1342-1344. PubMed ID: 30127167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical outcomes of cataract extraction by phacoemulsification in eyes with primary angle-closure glaucoma (PACG) and co-existing cataract: a prospective case series.
    Lai JS; Tham CC; Chan JC
    J Glaucoma; 2006 Feb; 15(1):47-52. PubMed ID: 16378018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
    Yang P; Liu X; Zhou H; Guo W; Zhou C; Kijlstra A
    Clin Exp Ophthalmol; 2011; 39(7):639-47. PubMed ID: 22452682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.